Genuit Share Discussion Threads

[dell314] 25/4/2003 15:05

I don't know about you Rambutan, but I'm starting to think this is a group of directors on the gravy train with very little interest in shareholders.
My patience is wearing out.....

[rambutan2] 25/4/2003 15:03

hmm, bit of a blow.

[dell314] 25/4/2003 14:36

I was hoping they might actually be about to make some money!!!


RNS Number:4009K
Generics Group AG
25 April 2003


The Generics Group AG ("Generics") announces that one of its investee companies,
Quantumbeam Limited, has today been placed in Administration, following a
decision by its shareholders not to invest further funds. Nicholas Guy Edwards
and Roderick John Weston of Deloitte Touche, 180 Strand, London, WC2R 1WL have
been appointed as joint administrators with a view to selling the business.

Quantumbeam Limited, in which Generics had invested intellectual property valued
at #2.4 million, is involved in the development of a novel low cost broadband
access technology using free space optics.

[rambutan2] 12/4/2003 00:27

the more throws of the dice they have the more chance of landing that big one! snowskating could just become this summers craze - perhaps!! and if not, heres a bit of more boring work theyve picked up...

11 April 2003

The Generics Group Wins DTI Contract to Research the Human Aspects of UK Digital TV Take-Up

The Generics Group (Generics), the integrated technology consulting, development and investment company, in association with Ipsos, a leading market research agency, has been appointed by the Department of Trade and Industry (DTI) to carry out research on how consumers engage with digital TV.

This study comes as part of the Digital Television Action Plan, working towards achieving analogue switch-off. The Government and Action Plan Stakeholders are looking to gain a better understanding of the factors that may be deterring consumers from adopting digital television services.

With nearly 60% of households in the UK yet to switch to digital, key objectives of the research are to:

gain a better understanding of the adoption process for households across all sectors of society;
identify issues around the usability of digital television for all consumers, with a special focus on individuals with special needs;
identify the drivers for adoption of digital TV;
discover the barriers to take-up; and
define the actions that need to be taken to overcome these barriers.

Stephen Timms, DTI e-Commerce Minister said: "Going digital will mean many benefits for consumers. Digital TV offers a wide range of new channels and enhanced sound and picture quality. It can also provide interactive services such as games and enhanced sports coverage.

"It is essential that people are fully aware of these benefits and that the technology is seen as easy to install and use. Through this research and through working closely with key industry players, we hope to develop a strategy to make digital television attractive to everyone in the UK."

Generics and Ipsos will carry out the study in close partnership with key stakeholders involved in the action plan. Their approach to the task will combine skills in product design, consumer research and technology policy. The programme will involve consumer surveys, focus groups, academic analysis and participation in the working groups set up under the Digital Television Action Plan. In addition to Ipsos, the Judge Institute of Management at the University of Cambridge is involved in the project.

The contract was won in an open competition and is expected to run until March 2004.

THE DIGITAL TELEVISION ACTION PLAN

The Digital Television Action Plan was formulated by the Government in partnership with stakeholders who have a primary interest in digital TV. These include broadcasters, manufacturers, retailers, platform operators and consumer groups.

The objective of the Action Plan is "To ensure that the criteria set for switchover are met so that Ministers can, if they so choose, take the decision to proceed to full switchover by ordering the switching off of analogue terrestrial transmission."

The Action Plan was first published in December 2001, and is updated quarterly. Information on the progress of the Action Plan, and on the Government's policies relating to digital television, can be found on www.digitaltelevision.gov.uk.

IPSOS
Ipsos UK is part of the Ipsos Group, the world's second largest survey-based research specialist. Founded in 1946, our reputation is based on our ability to combine the highest standards in data collection and analysis and our creativity in design and technology-based research solutions. That creativity is driven by our requirement to create the most cost effective research solutions to help our clients with their strategic decision-making

THE JUDGE INSTITUTE
The Judge Institute of Management is the University of Cambridge's business school. Founded in 1990, it has over 200 students and 70 teaching and research staff. It offers a portfolio of undergraduate, graduate and executive management programmes, including the Cambridge MBA. Teaching and Research benefit from a wide range of associate faculty in other departments within the university. The arrival of the Centre for Business Research means that the business school now hosts one of the largest concentrations of interdisciplinary business and management research activity in the Europe. For more details visit the Judge Institute of Management website www.jims.cam.ac.uk.

[maxwellsdemon] 10/4/2003 08:43

Latest patent application , published today:


PUBLISHED INTERNATIONAL APPLICATION
(11) WO 03/029487 (13) A2
(21) PCT/GB02/04398
(22) 30 September 2002 (30.09.2002)
(25) ENG (26) ENG
(31) 0123875.7 (32) 04 October 2001 (04.10.2001) GB
(31) 0216746.8 (32) 18 July 2002 (18.07.2002) GB
(43) 10 April 2003 (10.04.2003)
(51)7 C12Q 1/68
(54) DNA SEQUENCER

(71) SCIENTIFIC GENERICS LIMITED Harston Mill, Harston, Cambridgeshire CB2 5GG; (GB). [GB/GB].(for all designated States except US)
(72)(75) JONES, Aled, Wynne Scientific Generics Limited, Harston Mill, Harston, Cambridgeshire CB2 5GG; (GB) [GB/GB].KELLY, Peter, John KELLY, Peter, John; (GB) [GB/GB].TIMSON, Daniel, Reginald, Ewart TIMSON, Daniel, Reginald, Ewart; (GB) [GB/GB].REYNOLDS, Mike, Raymond REYNOLDS, Mike, Raymond; (GB) [GB/GB].VASILOPOULOS, Nicholas VASILOPOULOS, Nicholas; (GB) [GB/GR].
(74) BERESFORD, Keith, Denis, Lewis Beresford & Co., 2-5 Warwick Court, High Holborn, London WC1R 5DH; (GB).
(81)
AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW

(84)
ARIPO patent (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian patent (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European patent (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR), OAPI patent (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)

For information on time limits for entry into the national phase please click here
Published without international search report and to be republished upon receipt of that report



Abstract
A carrier carries a computer program for base calling DNA bases from a dataset corresponding to observed traces obtained from electrophoresis. The program generates a database in the computer memory corresponding to a model of a DNA sequence and refines the model of the DNA sequence by the following operations: (a) making a change to the base sequence of the model; (b) predicting the form of the traces from the modified model; (c) comparing the predicted traces with the observed traces in dataset to generate a penalty function; (d) determining whether or not to accept the modified model based on the value of the penalty function; and (e) repeating operations (a) to (d) until termination criteria have been achieved. The program has the advantage that it is less empirical and dependent on experimental setup than existing programs such as Phred.

[dell314] 02/4/2003 14:25

Rambutan - Thanks for updates.
However, it would be nice to actually see some shareholder value come from all this activity......

[rambutan2] 02/4/2003 14:21

ho hum, lets hope the next one is a multi million £ contract...

2 April 2003
Generics Invents Energy Saving Device

The Generics Group ('Generics'), the integrated technology development, consulting and investment organisation, has invented an energy saving technology for use in the home. BrightSwitch is a low-cost add-on device that can reduce energy costs for the consumer by up to 75%.

12V light fittings must be powered by transformers to provide safe low voltages. As the switch is ideally placed on the light fitting and not the transformer, the transformer is continuously powered, even when the light is off. By attaching the BrightSwitch to the transformer, it is automatically disconnected from the incoming mains voltage when the light is switched off. When it is switched on, the device restores power to the transformer.

The BrightSwitch carries the additional benefit of being a simple add-on part with no impact on the rest of the electrical design. It can be easily incorporated into existing products at the mains inlet, on the mains lead or at the wall plug and costs under £1/unit to produce. It has applications in domestic appliances - for example, lighting fixtures, fixed appliances and outdoor and portable devices – as well as audio systems, medical electronics, test and measurement systems and industrial controls.

Generics has filed a patent disclosure for the technology and carried out a laboratory proof of principle. The technology relies on the use of an electronic switch to control the power into the transformer. The controller uses the information from the built-in sensor to determine whether or not the load is connected even when the transformer is off. The device has its own internal power supply and will operate as soon as it is connected to the mains.

Joss Langford, inventor of the BrightSwitch, said: "We are confident this product would be welcomed by the 'green consumer', who is looking for ways of making his or her home more environmentally friendly. The BrightSwitch's potential in business-to- business markets is also significant. What we need now is a partner who will help us to exploit the product commercially."

[rambutan2] 27/3/2003 00:34

been sold back down to old levels since results and after the herald euphoria rise. good that the works still rolling in...

26 March 2003

Generics Helps Swedish FMV to develop Electrical Power Solutions for the Armed Forces

The Generics Group ('Generics'), the integrated technology development, consulting and investment organisation, has started work on a four-year framework agreement to support various projects for FMV (the Swedish Defence Materiel Administration). Generics' engagement with FMV also includes two technology foresight programmes, one looking 10 years ahead, the other 20 years ahead. These programmes focus on the electrical power solutions for the individual soldier and how battlefield technologies and power solutions will develop over these time periods.

During the four-year period, Generics will work with FMV on two key programmes on the following topics:

1) Developing a nickel-cadmium replacement strategy – nickel-cadmium is a key component of the batteries used by the military, not only in radios but also in many other appliances that are battery-dependant. Cadmium is a toxic substance that is very difficult to recycle safely and cheaply so the Swedish armed forces intend to move to an alternative battery technology that does not rely on this substance. The challenge to find a replacement is complicated by the need to provide one solution that works efficiently across all areas of military activity and is straightforward for soldiers to use.
2) Investigating and choosing a mobile fuel cell system to replace the present power system for a military application. This involves determining the design criteria and control system of the fuel cell system as well as addressing fulfilment of safety and environmental requirements.

FMV, which procures military equipment and services for the armed forces (air, sea and land), has been a client of Generics for almost 10 years. FMV has developed a reputation for being at the cutting-edge of technology for integrated military applications as a result of its proactive research programmes.

THE GENERICS GROUP
The Generics Group (Generics) is a leading integrated technology consulting, development and investment organisation, with an international reputation for successfully commercialising emerging science and technology.

Generics invest in and develop technologies that underpin the future of the widest range of industries. Its key areas of expertise include: engineering, materials, telecommunications, life sciences, business innovation and electronics.

Generics' facilities include state-of-the-art laboratories and are located in Europe in Cambridge, Frankfurt, Zürich, Switzerland and Stockholm; and in Boston and Baltimore in the USA. Generics have over 250 employees, of which 170 are high-caliber technology professionals.

FMV

FMV is an authority responsible directly to the Swedish government. FMV is responsible for the procurement and support of defence materiel throughout its life cycle from the initial study stage through to disposal. FMC's dominant customers are Sweden's armed forces. FMV employs about 2,100 personnel at sites located mainly in Stockholm but also in Arboga, Linköping, Karlsborg and Vidsel.

[otemple] 10/3/2003 14:20

Hello

Sorry to be a pain but i was wondering if you could help me by filling in my dissertation questionnaire researching investors opionions towards share options, specifically the issue of expensing them.

It is only short and will take approx. 3 minutes to complete.

You can access the dissertation online at:

Many thanks in advance to anyone who helps me with this.

Owen Temple

[maxwellsdemon] 10/3/2003 14:13

Intel - Broadreach


Major Intel announcement has Broadreach mentioned in numerous publications:

[dell314] 10/3/2003 10:08

A couple more stories:

[buchanan17] 07/3/2003 00:14

as long as you see it as a gamble, fine. They have to be around long enough to be able to sell the IP - and they afre hardly in a strong position as customers will realise they are getting cash strapped. Also, this stuff yakes forever to ge positive income stream. And patents aren't the holy grail they and people think (see TPPcom - below - they have relatviely few patents but rely on know how)

Their management over-reaches just as the wrong time - in early 90's they opened offices alll round the world (BTW - why do they need a german office now?), these all failed, were closed and there were redundancies then as there are now. And it is still the same core management of Edge and Hyde.

They've invested too much in blue sky stuff and neglected the cash engine needed in this sort of company - the consultancy. They are obviously trying to do a TTPCom - this was floated from TTP just down the road a couple of years back and has gone from strength to strength (to the benefit of TTPCom and original owners TTP) - see www.ttpcom.com - that is where you should invest!. One wonders if envy has coloured their judgement?

BTW - do all these links people are posting just mean that they have got very good PR? Media 90% responds to what it is sent! (Look at their web site - it is very good - so their PR is obviously good)

[rambutan2] 06/3/2003 10:36

buchanan, like just about everyone they didnt see such a big bear coming. theyve done what they said they would at flotation. yes, they should have cut back sooner, but cash outflow was inevitable. bvca valuation is pretty conservative and they dont use it for their accounts in any case, and they are just in the same situation as any other vc type co. the consulting side is getting better and the ip/vc side has massive blue sky potential. on top of that they have the building etc. yes its a punt, but i still like the odds at current mkt cap.

in any case, feature in the guardian today...

[buchanan17] 05/3/2003 20:40

rebound? It's lost £20million on a turnover of £13m!!!! How?? Gross mismanagement...

Its cash in the bank has dropped from £28m to £10m - i.e. it has virtually got through all flotation cash, and it has made huge redundancies. It has a new building (see the fancy graphic on its web site for an idea what it looks like) that is empty (I drive past it every morning on the way to slightly more successful company in Melbourn. This company is dead. Near enough. Will it last a year? Sell.

The BVCA valuation of £30m is ridiculous. IP is worth nothing unless you can sell it.

[2arona2] 04/3/2003 10:22

further drops to come but will rebound back in the next few days

[tony14] 04/3/2003 08:01

No surprise on the early markdown unfortunately, cash balance starting to look strained. Comments and opinions.

Regards

Edit:

LONDON (AFX) - Generics Group AG said its group pretax loss on ordinary
activities widened to 20.5 mln stg from 12.7 mln the year earlier.
Loss per share was 16.5 pence from 10.3 pence the year earlier.
Gordon Edge, Generics' non-executive chairman, said: "2002 was a year which
presented Generics with a number of significant challenges. Although the results
for the year are disappointing, I believe that the Group has performed
creditably in the circumstances."
Turnover was up 2 pct year on year to 13.0 mln stg, while consulting order
intake up 6 pct to 15.7 mln stg.
"Generics managed to grow both turnover and orders in difficult consulting
markets while at the same time taking out an annualised 2.5 mln stg in two cost
savings programmes, including the implementation of a salary reduction scheme.
However, he said the consulting business will not be at breakeven in the
first quarter as a result of the continuing weak market.
He also said that several of the group's companies represent attractive
acquisition opportunities, while at the same time, it has taken measures to
conserve cash and to limit investment to only the most promising of our
portfolio companies.
rf/

[maxwellsdemon] 03/3/2003 17:53

snape,

Thanks. Here is Katie P's resumé:

[snape] 03/3/2003 17:40

Katie P normally does her homework.
I admit I have been copying and am hoping marks are good tomorrow!

[rambutan2] 03/3/2003 16:57

lets hope that our new institutional shareholder was heralding good news!

[snape] 03/3/2003 16:46

Be good. Pls

[boram] 02/3/2003 17:02

Generics Group, Finals are out on Tuesday 4th.

[jam1nman] 01/3/2003 00:12

Nice rise this morning,long may it continue.This share is heading north at last.Looking forward to Tuesday's results.